Public Sector Pension Investment Board (PSP Investments)’s Apellis Pharmaceuticals APLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-366,674
Closed -$14.8M 1342
2026
Q1
$14.8M Buy
+366,674
New +$7.9M 0.05% 370

Other funds holding APLS

Public Sector Pension Investment Board (PSP Investments)'s APLS Position: Q2 2026 in Review

Public Sector Pension Investment Board (PSP Investments) sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 366,674 shares — an estimated $14.8M sold.

Public Sector Pension Investment Board (PSP Investments) first reported a position in APLS in Q1 2026 and held it in 1 quarter. The position peaked at $14.8M in Q1 2026. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

  • Public Sector Pension Investment Board (PSP Investments) reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Public Sector Pension Investment Board (PSP Investments) sold 366,674 Apellis Pharmaceuticals shares in Q2 2026, an estimated $14.8M.
  • Public Sector Pension Investment Board (PSP Investments) first reported a position in Apellis Pharmaceuticals in Q1 2026 and held it in 1 quarter.
  • Public Sector Pension Investment Board (PSP Investments)'s Apellis Pharmaceuticals position peaked at $14.8M in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on Public Sector Pension Investment Board (PSP Investments)'s 13F filing for Q2 2026, filed 13 Aug 2026.